Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian Gabrielli

Showing results (71-80 of 82) with videos related to

Pageof 9
Sort By:
Molecular Oncology|November 17, 2019
Multiple interaction nodes define the postreplication repair response to UV-induced DNA damage that is defective in melanomas and correlated with UV signature mutation loadSandra Pavey, Alex Pinder, Winnie Fernando, et al.
International Journal of Molecular Sciences|February 10, 2024
The ATM Ser49Cys Variant Effects ATM Function as a Regulator of Oncogene-Induced SenescenceCaroline Atkinson, Aideen M McInerney-Leo, Martina Proctor, et al.
Oncotarget|November 24, 2016
Genome-wide gain-of-function screen for genes that induce epithelial-to-mesenchymal transition in breast cancerDubravka Škalamera, Mareike Dahmer-Heath, Alexander J Stevenson, et al.
Cell Death & Disease|November 9, 2024
Aurora B inhibitors promote RB hypophosphorylation and senescence independent of p53-dependent CDK2/4 inhibitionShivam Vora, Ariel Andrew, Ramyashree Prasanna Kumar, et al.
EMBO Molecular Medicine|August 16, 2018
CEP55 is a determinant of cell fate during perturbed mitosis in breast cancerMurugan Kalimutho, Debottam Sinha, Jessie Jeffery, et al.
British Journal of Cancer|January 29, 2024
Inhibition of Aurora B kinase (AURKB) enhances the effectiveness of 5-fluorouracil chemotherapy against colorectal cancer cellsEsha T Shah, Christopher Molloy, Madeline Gough, et al.
Cell Death & Disease|January 8, 2025
Aurora B inhibition induces hyper-polyploidy and loss of long-term proliferative potential in RB and p53 defective cellsShivam Vora, Saptarshi Chatterjee, Ariel Andrew, et al.
Molecular Cancer Therapeutics|October 31, 2015
Aurora A Is Critical for Survival in HPV-Transformed Cervical CancerBrian Gabrielli, Fawzi Bokhari, Max V Ranall, et al.
Oncotarget|March 2, 2018
Distinct histone modifications denote early stress-induced drug tolerance in cancerAbdullah Al Emran, Diego M Marzese, Dinoop Ravindran Menon, et al.
British Journal of Cancer|April 7, 2026
Using targeted therapy to promote a pro-inflammatory tumour microenvironment and anti-tumour immune response in high grade serous ovarian cancerZhen Zeng, Anastasia Gandini, Rituparna Bhatt, et al.
Pageof 9

Showing results (71-80 of 82) with videos related to

Sort By:
Pageof 9
Molecular Oncology|November 17, 2019
Multiple interaction nodes define the postreplication repair response to UV-induced DNA damage that is defective in melanomas and correlated with UV signature mutation loadSandra Pavey, Alex Pinder, Winnie Fernando, et al.
International Journal of Molecular Sciences|February 10, 2024
The ATM Ser49Cys Variant Effects ATM Function as a Regulator of Oncogene-Induced SenescenceCaroline Atkinson, Aideen M McInerney-Leo, Martina Proctor, et al.
Oncotarget|November 24, 2016
Genome-wide gain-of-function screen for genes that induce epithelial-to-mesenchymal transition in breast cancerDubravka Škalamera, Mareike Dahmer-Heath, Alexander J Stevenson, et al.
Cell Death & Disease|November 9, 2024
Aurora B inhibitors promote RB hypophosphorylation and senescence independent of p53-dependent CDK2/4 inhibitionShivam Vora, Ariel Andrew, Ramyashree Prasanna Kumar, et al.
EMBO Molecular Medicine|August 16, 2018
CEP55 is a determinant of cell fate during perturbed mitosis in breast cancerMurugan Kalimutho, Debottam Sinha, Jessie Jeffery, et al.
British Journal of Cancer|January 29, 2024
Inhibition of Aurora B kinase (AURKB) enhances the effectiveness of 5-fluorouracil chemotherapy against colorectal cancer cellsEsha T Shah, Christopher Molloy, Madeline Gough, et al.
Cell Death & Disease|January 8, 2025
Aurora B inhibition induces hyper-polyploidy and loss of long-term proliferative potential in RB and p53 defective cellsShivam Vora, Saptarshi Chatterjee, Ariel Andrew, et al.
Molecular Cancer Therapeutics|October 31, 2015
Aurora A Is Critical for Survival in HPV-Transformed Cervical CancerBrian Gabrielli, Fawzi Bokhari, Max V Ranall, et al.
Oncotarget|March 2, 2018
Distinct histone modifications denote early stress-induced drug tolerance in cancerAbdullah Al Emran, Diego M Marzese, Dinoop Ravindran Menon, et al.
British Journal of Cancer|April 7, 2026
Using targeted therapy to promote a pro-inflammatory tumour microenvironment and anti-tumour immune response in high grade serous ovarian cancerZhen Zeng, Anastasia Gandini, Rituparna Bhatt, et al.
Pageof 9